levetiracetam
Generic: levetiracetam
Labeler: mylan pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
levetiracetam
Generic Name
levetiracetam
Labeler
mylan pharmaceuticals inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
levetiracetam 1000 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0378-5619
Product ID
0378-5619_8eaa3318-fe96-4d3e-9f49-3286cb04bfbf
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090261
Listing Expiration
2026-12-31
Marketing Start
2009-12-10
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
03785619
Hyphenated Format
0378-5619
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
levetiracetam (source: ndc)
Generic Name
levetiracetam (source: ndc)
Application Number
ANDA090261 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1000 mg/1
Packaging
- 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5619-91)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8eaa3318-fe96-4d3e-9f49-3286cb04bfbf", "openfda": {"nui": ["N0000008486"], "unii": ["44YRR34555"], "rxcui": ["311289", "311290", "387003"], "spl_set_id": ["0a987d59-560f-4650-96ec-31aec81953b5"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-5619-91)", "package_ndc": "0378-5619-91", "marketing_start_date": "20091210"}], "brand_name": "Levetiracetam", "product_id": "0378-5619_8eaa3318-fe96-4d3e-9f49-3286cb04bfbf", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0378-5619", "generic_name": "levetiracetam", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "1000 mg/1"}], "application_number": "ANDA090261", "marketing_category": "ANDA", "marketing_start_date": "20091210", "listing_expiration_date": "20261231"}